ASP list receives 1.39% lift; Albuterol drops more than 10%
The average sales price (ASP) drug list covered by Part B will receive an overall increase for the second quarter that starts April 1, according to an analysis by Part B News.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.